These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 17961306

  • 1. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
    Xie XY, Yang X, Zhang JH, Liu ZJ.
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
    [Abstract] [Full Text] [Related]

  • 2. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 3. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [Abstract] [Full Text] [Related]

  • 4. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
    Longchampt E, Lebret T, Molinie V, Bieche I, Botto H, Lidereau R.
    Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
    [Abstract] [Full Text] [Related]

  • 5. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y, Tsuchida T, Fukasawa M, Araki I, Tanabe N, Takeda M.
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [Abstract] [Full Text] [Related]

  • 6. Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K, Hiroi S, Kawai T, Aida S, Kasamatsu H, Aurues T, Ikeda T.
    Mod Pathol; 2001 Nov; 14(11):1073-8. PubMed ID: 11706066
    [Abstract] [Full Text] [Related]

  • 7. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

  • 8. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH.
    Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Detection of telomerase hTERT gene expression of exfoliated cell in broncho-alveolar lavage fluid].
    Ma G, Gao JS, Tong M, Xiong JG, He YS, Rong TH.
    Ai Zheng; 2002 May; 21(5):533-5. PubMed ID: 12452048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
    Christoph F, Weikert S, Wolff I, Schostak M, Tabiti K, Müller M, Miller K, Schrader M.
    Cancer Lett; 2007 Jan 08; 245(1-2):121-6. PubMed ID: 16473461
    [Abstract] [Full Text] [Related]

  • 14. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W, Xu Z.
    Int J Urol; 2007 Feb 08; 14(2):108-11. PubMed ID: 17302565
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
    Kitsukawa S, Aoyagi T, Noda K, Ito T, Yamamoto Y, Hosoda S, Otsuru N, Matsumoto T.
    Hinyokika Kiyo; 2008 Feb 08; 54(2):101-6. PubMed ID: 18323166
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
    Amsellem-Ouazana D, Bièche I, Molinié V, Elie C, Vieillefond A, Tozlu S, Botto H, Debré B, Lidereau R.
    Eur Urol; 2006 Jun 08; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
    [Abstract] [Full Text] [Related]

  • 19. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH, Yang SC, Hong SJ, Chung BH, Kim IY.
    Clin Cancer Res; 1998 Mar 08; 4(3):535-8. PubMed ID: 9533519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.